Medicare Enrolled
Dr. Jaimie Heckman, CRNP
Urology Registered Nurse · Wyomissing, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Heckman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Heckman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Heckman
Dr. Jaimie Heckman is an urology registered nurse in Wyomissing, PA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Heckman performed 7,286 Medicare services across 3,704 unique beneficiaries.
Between the years covered by Open Payments, Dr. Heckman received a total of $4,284 from 37 pharmaceutical and/or device companies across 194 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology registered nurse. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Heckman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ 7,286 Medicare services
$4,284 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,286
Medicare services
1.0× state median for urology registered nurse
3,704
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~662 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
1,831 | $34 | $53 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,310 | $72 | $267 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
1,067 | $3 | $12 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
747 | $7 | $146 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 553 | $136 | $650 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
423 | $69 | $105 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
399 | $50 | $184 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
141 | $34 | $53 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
141 | $34 | $53 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
141 | $34 | $53 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
96 | $20 | $85 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
91 | $7 | $175 |
| Simple change of bladder tube | 71 | $58 | $238 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
71 | $8 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
47 | $98 | $406 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
39 | $52 | $132 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
38 | $113 | $295 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
28 | $37 | $162 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
18 | $227 | $690 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
18 | $123 | $360 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $30 | $111 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,284
Total received (2021-2024)
Avg $1,071/year across 4 years
1.0× state median for specialty
37
Companies
194
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,047 (94.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$236 (5.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,575
2023
$1,075
2022
$885
2021
$749
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$275
Bayer Healthcare Pharmaceuticals Inc.
$203
180 Medical, Inc.
$176
Janssen Biotech, Inc.
$123
ABBVIE INC.
$108
PFIZER INC.
$87
Abbott Laboratories
$87
Novartis Pharmaceuticals Corporation
$70
Tempus AI, Inc
$55
ConvaTec Inc.
$51
Tolmar, Inc.
$49
UROGEN PHARMA, INC.
$47
COLOPLAST CORP
$41
Astellas Pharma US Inc
$38
Ferring Pharmaceuticals Inc.
$38
Dendreon Pharmaceuticals LLC
$32
DENTSPLY IH AB
$32
Endo USA, Inc.
$31
Telix Pharmaceuticals
$19
Merck Sharp & Dohme LLC
$13
Top 3 companies account for 41.5% of 2024 payments
All-time payments by company (2021-2024) ›
Janssen Biotech, Inc.
$698
Sumitomo Pharma America, Inc.
$404
Astellas Pharma US Inc
$374
ABBVIE INC.
$321
180 Medical, Inc.
$308
Bayer Healthcare Pharmaceuticals Inc.
$260
PFIZER INC.
$156
UroGen Pharma, Inc.
$154
ConvaTec Inc.
$151
AstraZeneca Pharmaceuticals LP
$140
EMD Serono, Inc.
$124
Novartis Pharmaceuticals Corporation
$121
UROVANT SCIENCES INC
$119
Abbott Laboratories
$87
Teleflex LLC
$72
AbbVie Inc.
$70
DENTSPLY IH Inc.
$65
Tolmar, Inc.
$64
COLOPLAST CORP
$55
Tempus AI, Inc
$55
Bayer HealthCare Pharmaceuticals Inc.
$54
UROGEN PHARMA, INC.
$47
Myovant Sciences Inc.
$41
Ferring Pharmaceuticals Inc.
$38
Blue Earth Diagnostics Limited
$34
Dendreon Pharmaceuticals LLC
$32
DENTSPLY IH AB
$32
Endo USA, Inc.
$31
Coloplast Corp
$28
Medtronic, Inc.
$23
E.R. Squibb & Sons, L.L.C.
$21
Clarus Therapeutics Inc.
$20
Telix Pharmaceuticals
$19
Accord Healthcare, Inc.
$18
Axonics, Inc.
$18
Endo Pharmaceuticals Inc.
$17
Merck Sharp & Dohme LLC
$13
Top 3 companies account for 34.4% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · Axonics · Axumin · BALVERSA · BAVENCIO · BOTOX · CAMCEVI · ELIGARD · ERLEADA · GEMTESA · GENTLECATH · GENTLECATH GLIDE · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · JETI PERIPHERAL CATHETER · KEYTRUDA · LOFRIC · LUPRON DEPOT · LYNPARZA · LoFric · Luja Coude · MYRBETRIQ · Myrbetriq · Nubeqa · OPDIVO · ORGOVYX · PLUVICTO · PROVENGE · SPEEDICATH · SpeediCath · UROLIFT · UroLift System · XIAFLEX · XTANDI · Xofigo · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology registered nurses within 10 mi
1
Per 100K population
0.2
County median income
$77,684
Nearest hospital
SURGICAL INSTITUTE OF READING
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Heckman is a clinical cardiology specialist, with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Heckman experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Heckman performed 1,831 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Heckman receive payments from pharmaceutical companies?
Yes. Dr. Heckman received a total of $4,284 from 37 companies across 194 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Heckman's costs compare to other urology registered nurses in Wyomissing?
Dr. Heckman's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Heckman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Registered Nurses in Wyomissing
Browse urology registered nurses in Wyomissing ranked by procedure volume and transparency data.
Highest volume
Top Urology Registered Nurses in PA
Urology registered nurses ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Registered Nurses in PA
Which PA urology registered nurses receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology